Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boehringer Ingelheim
Fierce Pharma
US reveals new Medicare prices for second round of IRA drugs
The U.S. has revealed price reductions for 15 prescription drugs negotiated by Medicare through the IRA, headlined by Novo Nordisk's semaglutide.
Kevin Dunleavy
Nov 26, 2025 11:42am
Brainomix snags $18M; Proscia picks up $50M—Fundraising Tracker
Mar 21, 2025 3:00pm
Chutes & Ladders—Stanford Children's taps new president, COO
Feb 20, 2025 2:45pm
Boehringer, GoodRx team to boost access to Humira biosimilars
Jul 18, 2024 3:00pm
Walgreens inks deal with Boehringer Ingelheim on clinical trials
May 2, 2024 8:00am
HRSA calls for Boehringer Ingelheim to be fined for 340B moves
Mar 31, 2022 7:10am